Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • Newsroom
  • Publications & data
  • Tools
  • About us

Search

Filter by:
Page 1 of 7 // 65 Results found

Publication

Rapid risk assessment: Increase in OXA-244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013, first update

Risk assessment - 20 Jul 2021

Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.

Rapid risk assessment: Increase in OXA -244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013, first update - EN - [PDF-704.3 KB]
  • Antimicrobial resistance
  • Denmark
  • Escherichia coli infection
  • Finland
  • France
  • Germany
  • Healthcare-associated infections
  • Ireland
  • Luxembourg
  • Microbiology
  • Netherlands
  • Norway
  • Sweden
  • United Kingdom
  • Whole genome sequencing

Data

Country profile for Norway

Country profile - 19 Mar 2019

Country profile for Norway based on 2017 surveillance data

  • Norway
  • Surveillance
  • Tuberculosis

Publication

ECDC country visit to Norway to discuss antimicrobial resistance issues

Mission report - 16 Jan 2019

An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.

ECDC country visit to Norway to discuss antimicrobial resistance issues - EN - [PDF-702.82 KB]
  • Antimicrobial resistance
  • Carbapenem-resistant Enterobactericae
  • Hospital-acquired infections
  • Infections in long-term care facilities
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Norway

An updated meta-analysis of the distribution and prevalence of Borrelia burgdorferi s.l. in ticks in Europe

Peer-Reviewed Publication

Dec 2018 - Int J Health Geogr - 17(1):41

Estrada-Peña, A., Cutler, S., Potkonjak, A., Vassier-Tussaut, M., Bortel, W., Zeller, H., Fernández-Ruiz, N., Mihalca, A.D.

  • Borreliosis
  • Climate change
  • Epidemic intelligence
  • EU/EEA
  • Europe
  • Iceland
  • Liechtenstein
  • Norway
  • Scientific advice
  • Switzerland
  • Training
  • Transmission of disease

News

Epidemiological update: Multi-country outbreak of Salmonella Enteritidis infections linked to Polish eggs

Epidemiological update - 19 Nov 2018

Since the latest ECDC-EFSA rapid outbreak assessment published on 12 December 2017, 15 EU/EEA countries (Belgium, Czech Republic, Denmark, France, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Slovenia, Sweden and United Kingdom) have reported 336 confirmed, 94 probable and 3 new historical-confirmed cases associated with this ongoing multi-country outbreak of Salmonella Enteritidis in the EU/EEA.

  • Belgium
  • Czech Republic
  • Denmark
  • France
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Luxembourg
  • Microbiology
  • Molecular typing
  • Netherlands
  • Norway
  • Poland
  • Public health threat
  • Salmonella Enteritidis
  • Salmonellosis
  • Slovenia
  • Sweden
  • United Kingdom

HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets

Peer-Reviewed Publication

Nov 2018 - Euro Surveill. - 23(48):1800622

Brown, A.E., Hayes, R., Noori, T., Azad, Y., Amato-Gauci, A.J., Pharris, A., Delpech, V.C., The Ecdc Dublin Declaration Monitoring Network

  • Albania
  • Andorra
  • Armenia
  • Austria
  • Azerbaijan
  • Belarus
  • Belgium
  • Bulgaria
  • Central Asia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Epidemic
  • Estonia
  • EU/EEA
  • Europe
  • Finland
  • France
  • Georgia
  • Germany
  • HIV infection
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Kazakhstan
  • Kosovo*
  • Kyrgyzstan
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Moldova
  • Monaco
  • Montenegro
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Prevention and control
  • Public health response
  • Romania
  • Russia
  • Serbia
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • Tajikistan
  • The Republic of North Macedonia
  • Transmission of disease
  • Turkey
  • Ukraine
  • United Kingdom
  • Uzbekistan

News

Epidemiological update - Increase in Echovirus 30 detections in Denmark, Germany, the Netherlands, Norway and Sweden, June to July 2018

Epidemiological update - 31 Aug 2018

In 2018, Norway [1] and the Netherlands [2] published reports from national public health institutes on increased Echovirus 30 (E30) detections associated with an increase in the number of meningitis or meningoencephalitis cases. Since the beginning of 2018, 407 E30 cases have been reported to ECDC in 10 EU/EEA countries based on an Epidemic Intelligence Information System–Vaccine Preventable Diseases (EPIS-VPD) data call.

  • Denmark
  • Enterovirus
  • Germany
  • Netherlands
  • Norway
  • Public health threat
  • Sweden

News

Epidemiological update - Increase in Echovirus 30 detections in Denmark, the Netherlands, Norway and Sweden, July 2018

Epidemiological update - 3 Aug 2018

Since the beginning of the year, certain EU/EEA public health institutes have observed an upsurge in the number of positive enterovirus detections, especially Echovirus 30 (E30) cases. Norway [1] and the Netherlands [2] have published a report from national public health institutes on the increased E30 detections.

  • Denmark
  • Enterovirus
  • Netherlands
  • Norway
  • Public health threat
  • Sweden

Publication

Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain

Risk assessment - 11 Jul 2018

This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.

RRA: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain - EN - [PDF-1.04 MB]
  • Antimicrobial resistance
  • Finland
  • Healthcare-associated infections
  • Klebsiella pneumoniae
  • Norway
  • Public health threat
  • Scientific advice
  • Spain
  • Sweden
  • Travel related infections

Publication

Joint rapid outbreak assessment: Multi-country outbreak of Salmonella Enteritidis infections linked to Polish eggs

Risk assessment - 12 Dec 2017

This document provides an assessment of the public health risk associated with a multi-country outbreak of Salmonella Enteritidis, which is epidemiologically and microbiologically linked to contaminated eggs from Poland, and can be characterised by at least six MLVA profiles and four clusters defined by WGS (PHE SNP analysis).

Multi-country outbreak of Salmonella Enteritidis infections linked to Polish eggs - EN - [PDF-985.39 KB]
  • Belgium
  • Czech Republic
  • EU/EEA
  • France
  • Luxembourg
  • Netherlands
  • Norway
  • Public health threat
  • Salmonella Enteritidis
  • Salmonellosis
  • Scientific advice
  • Sweden
  • United Kingdom

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy
  • Personal data protection
  • Language policy
  • Cookies
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2022
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Search:
  • Home
  • All topics: A to Z
  • Newsroom
  • Publications & data
  • Tools
  • About us